Asan Medical Center
Clinical trials sponsored by Asan Medical Center, explained in plain language.
-
Immunotherapy combo shows promise against stomach cancer in early trial
Disease control CompletedThis phase 2 trial tested adding the immunotherapy drug durvalumab to a standard chemotherapy regimen (docetaxel, oxaliplatin, S-1) before and after surgery in 68 patients with resectable stomach or gastroesophageal junction cancer. The main goal was to see how many patients had …
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New combo shows promise for stomach cancer patients with hidden HER2 signal
Disease control CompletedThis phase II study tested whether adding trastuzumab (a targeted therapy) to standard chemotherapy could help people with advanced stomach or gastroesophageal junction cancer. Unlike typical patients, these participants had tumors that tested negative for HER2 in tissue but posi…
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Chemotherapy drug paclitaxel tested for Hard-to-Treat GIST
Disease control CompletedThis phase II trial tested the chemotherapy drug paclitaxel in 40 patients with advanced or metastatic gastrointestinal stromal tumor (GIST) whose cancer had stopped responding to three standard treatments: imatinib, sunitinib, and regorafenib. The study focused on patients with …
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Ultrasound-Guided stents may keep leg arteries open longer
Disease control CompletedThis study tested whether using intravascular ultrasound (a tiny camera inside the artery) to guide stent placement in the leg is better than the usual X-ray guidance. One hundred people with blocked leg arteries were randomly assigned to one of the two methods. The goal was to s…
Phase: NA • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Ovarian cancer drug niraparib tested in 850 korean women
Disease control CompletedThis study looked at how effective and safe niraparib is for Korean women with epithelial ovarian cancer. It included 850 patients who took niraparib as maintenance therapy or as a later treatment. Researchers measured how long patients lived without their cancer getting worse an…
Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Eye injection shows promise for diabetic retinopathy
Disease control CompletedThis study tested whether aflibercept injections into the eye can improve areas of poor blood flow in the retina of people with diabetic retinopathy. 38 adults with nonproliferative diabetic retinopathy received the treatment. The goal was to see if the drug could reduce the risk…
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Wrist access may ease liver cancer treatment
Disease control CompletedThis study tested a new way to deliver chemo directly to liver tumors using a wrist artery instead of the groin. Thirty-eight patients with liver cancer took part. The goal was to see if the wrist approach is safe, feasible, and effective, with fewer complications and faster reco…
Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 26, 2026 14:47 UTC
-
New wearable device could uncover hidden stroke cause
Diagnosis CompletedThis study tested a wearable heart monitor called Cardea SOLO against a standard 12-lead EKG to see if it could better detect paroxysmal atrial fibrillation (a temporary irregular heartbeat) in people who had a stroke of unknown cause and have an enlarged heart. 257 participants …
Phase: NA • Sponsor: Asan Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
New scan could spot breast cancer spread without surgery
Diagnosis CompletedThis study tests whether a special PET scan using a radioactive tracer called FES can accurately detect breast cancer that has spread to lymph nodes under the arm. Researchers will scan 71 people with estrogen-positive breast cancer and compare the results to standard methods. If…
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Smart dosing of antibiotics may cut infection risk after colon surgery
Prevention CompletedThis study tested whether giving the antibiotic cefoxitin using a target-controlled infusion pump works better than the standard method to prevent surgical site infections in patients having colon or rectal surgery. About 2,500 adults took part. The goal was to see if the new met…
Phase: NA • Sponsor: Asan Medical Center • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
Video game therapy gets bedridden patients back on their feet
Symptom relief CompletedThis study tested whether using a motion-tracking exergame (Nintendo Ring Fit) in bed is safe and doable for patients who cannot walk. 26 adults who were bedridden after organ transplants or critical care played personalized exercise games for 30 minutes daily over two weeks, sup…
Phase: NA • Sponsor: Asan Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
App-Based exercises help bedridden patients get moving again
Symptom relief CompletedThis study tested whether a rehabilitation program using a smartphone app (MORA) could help bedridden hospital patients improve their physical function. Twenty-five adults who could not walk used the app to do personalized exercises twice daily for two weeks. The goal was to see …
Phase: NA • Sponsor: Asan Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Can a smartphone app keep cancer patients out of the hospital?
Symptom relief CompletedThis study tested whether a mobile app that lets cancer patients report their symptoms to their doctor can reduce unplanned hospital visits. 166 adults with solid cancers on systemic therapy participated. Half used the app before clinic visits, while the other half had usual care…
Phase: NA • Sponsor: Asan Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Mapping the danger zones: new ultrasound study aims to make vein access safer
Knowledge-focused CompletedThis study uses ultrasound to measure the distance between the subclavian vein and nearby risky structures like the lung and artery. Researchers will compare two ultrasound probe positions (above vs below the collarbone) and check if arm position changes the safety margins. About…
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could a common cholesterol pill shield heart during liver transplant?
Knowledge-focused CompletedThis study looked back at the records of nearly 7,000 adults who had a liver transplant to see if taking statins beforehand lowered their risk of major heart problems. Researchers checked for events like heart attack, stroke, and heart failure within 30 days after surgery. The go…
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
MRI clues may predict who gets pain relief from neck injection
Knowledge-focused CompletedThis study looked back at the medical records of 90 adults with neck and arm pain caused by a pinched nerve. Researchers wanted to see if MRI scans could predict who would get good pain relief from a procedure called a stellate ganglion block, where numbing medicine is injected n…
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Waistline may predict surgery time for rare adrenal tumor
Knowledge-focused CompletedThis study looked at whether a patient's abdominal circumference (belly size) is linked to how long surgery takes to remove a pheochromocytoma, a rare adrenal tumor. Researchers reviewed records of 159 adults who had the surgery. The goal was to see if belly size could help docto…
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Can a simple model predict who will survive surgery? study of 640,000 patients says maybe.
Knowledge-focused CompletedResearchers analyzed data from over 640,000 adults who had non-cardiac surgery to create a model that predicts the chance of dying within 30 days, 180 days, and one year after surgery. The model uses information from hospital records and national death registries. This study is c…
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
New study analyzes best donor match for AML stem cell transplants
Knowledge-focused CompletedThis completed study looked at 98 adults with acute myeloid leukemia (AML) in first remission who received a stem cell transplant from a matched sibling, matched unrelated, or half-matched family donor. All patients got the same chemotherapy conditioning before transplant. Resear…
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:52 UTC
-
Blood samples may reveal how to stop transplant complications
Knowledge-focused CompletedThis completed study involved 146 patients with blood cancers who received a stem cell transplant from a donor. Researchers collected blood and tissue samples over a year to study immune cells linked to graft-versus-host disease (GVHD), a common complication where donor cells att…
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:53 UTC